CFP
TMO icon

Catalyst Financial Partners’s Thermo Fisher Scientific TMO Stock Holding History

Catalyst Financial Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.14M Buy
2,272
+29
+1% +$13.9K 0.11% 103
2026
Q1 		$1.1M Buy
2,243
+32
+1% +$17.4K 0.13% 99
2025
Q4 		$1.28M Buy
2,211
+369
+20% +$209K 0.14% 78
2025
Q3 		$893K Buy
1,842
+101
+6% +$47K 0.11% 100
2025
Q2 		$706K Sell
1,741
-181
-9% -$75.7K 0.08% 126
2025
Q1 		$956K Buy
1,922
+72
+4% +$39K 0.18% 66
2024
Q4 		$962K Sell
1,850
-61
-3% -$33.5K 0.18% 67
2024
Q3 		$1.18M Sell
1,911
-3
-0.2% -$1.78K 0.23% 55
2024
Q2 		$1.06M Buy
1,914
+116
+6% +$66.5K 0.23% 56
2024
Q1 		$984K Buy
1,798
+167
+10% +$93.7K 0.25% 48
2023
Q4 		$866K Buy
1,631
+110
+7% +$53.2K 0.24% 56
2023
Q3 		$770K Buy
1,521
+659
+76% +$351K 0.25% 61
2023
Q2 		$450K Buy
862
+72
+9% +$38.9K 0.16% 93
2023
Q1 		$455K Buy
790
+84
+12% +$47.3K 0.2% 76
2022
Q4 		$389K Buy
+706
New +$374K 0.2% 78

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Catalyst Financial Partners's TMO Position: Q2 2026 in Review

Catalyst Financial Partners increased its Thermo Fisher Scientific (TMO) stake by 1.3% in Q2 2026, buying an estimated $13.9K and bringing the position to 2,272 shares worth $1.14M. The position accounts for 0.11% of the portfolio, ranked #103.

Catalyst Financial Partners first reported a position in TMO in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.28M in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Catalyst Financial Partners held 2,272 shares of Thermo Fisher Scientific worth $1.14M as of Q2 2026.
  • Catalyst Financial Partners bought 29 Thermo Fisher Scientific shares in Q2 2026, an estimated $13.9K.
  • Thermo Fisher Scientific made up 0.11% of Catalyst Financial Partners's portfolio in Q2 2026, its #103 holding.
  • Catalyst Financial Partners first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 15 quarters since.
  • Catalyst Financial Partners's Thermo Fisher Scientific position peaked at $1.28M in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Catalyst Financial Partners's 13F filing for Q2 2026, filed 30 Jul 2026.